• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

睾酮缺乏症是慢性肾脏病的主要内分泌紊乱之一。

Testosterone Deficiency as One of the Major Endocrine Disorders in Chronic Kidney Disease.

机构信息

Department of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine, 128 Szaserów Street, 04-141 Warsaw, Poland.

出版信息

Nutrients. 2022 Aug 21;14(16):3438. doi: 10.3390/nu14163438.

DOI:10.3390/nu14163438
PMID:36014945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9415930/
Abstract

Reduced testosterone concentration is nowadays thought to be one of the main endocrine disorders in chronic kidney disease (CKD). It is caused by the dysfunction of the hypothalamic-pituitary-gonadal axis. The role of testosterone is multifactorial. Testosterone is responsible not only for reproductive processes, but it is a hormone which increases bone and muscle mass, improves lipid profile, insulin sensitivity, erythropoiesis, reduces blood pressure, and ameliorates mood and perception. The implications of hypogonadism in CKD are infertility and loss of libido, reduction of muscle mass and strength, disorders in bone mineralization, the development of sarcopenia and protein energy wasting (PEW), progression of atherosclerosis, increased visceral adiposity, insulin resistance, and anaemia. Reduced testosterone serum concentrations in CKD are associated with increased mortality rate. Testosterone supplementation improves sexual functions, reduces the level of inflammatory markers and blood pressure, stimulates muscle protein synthesis, improves insulin sensitivity and lipid profile, and increases muscle mass, bone mineral density, and haemoglobin concentration. It positively affects mood and well-being. The modes of testosterone supplementation are intramuscular injections, subcutaneous pellets, and percutaneous methods-patches and gels. Successful kidney transplantation may improve gonadal function and testosterone production, however, half of men with low testosterone concentrations before kidney transplantation do not restore hormonal function.

摘要

如今,人们认为睾丸酮浓度降低是慢性肾脏病(CKD)的主要内分泌紊乱之一。它是由下丘脑-垂体-性腺轴功能障碍引起的。睾丸酮的作用是多方面的。睾丸酮不仅负责生殖过程,还是一种增加骨量和肌肉量、改善血脂谱、提高胰岛素敏感性、促进红细胞生成、降低血压以及改善情绪和认知的激素。性腺功能减退症在 CKD 中的影响包括不孕和性欲降低、肌肉量和力量减少、骨矿物质化紊乱、发生肌肉减少症和蛋白质能量消耗(PEW)、动脉粥样硬化进展、内脏脂肪增加、胰岛素抵抗和贫血。CKD 患者血清睾丸酮浓度降低与死亡率增加有关。睾丸酮补充治疗可改善性功能,降低炎症标志物和血压水平,刺激肌肉蛋白合成,改善胰岛素敏感性和血脂谱,增加肌肉量、骨密度和血红蛋白浓度。它还可以积极改善情绪和健康状况。睾丸酮补充的方式有肌肉内注射、皮下埋植剂和经皮贴剂和凝胶。成功的肾移植可能会改善性腺功能和睾丸酮生成,但一半在肾移植前睾丸酮浓度低的男性并未恢复激素功能。

相似文献

1
Testosterone Deficiency as One of the Major Endocrine Disorders in Chronic Kidney Disease.睾酮缺乏症是慢性肾脏病的主要内分泌紊乱之一。
Nutrients. 2022 Aug 21;14(16):3438. doi: 10.3390/nu14163438.
2
Testosterone deficiency and chronic kidney disease.睾酮缺乏与慢性肾脏病
J Clin Transl Endocrinol. 2024 Aug 14;37:100365. doi: 10.1016/j.jcte.2024.100365. eCollection 2024 Sep.
3
Testosterone Disorders and Male Hypogonadism in Kidney Disease.肾脏疾病中的睾酮紊乱与男性性腺功能减退
Semin Nephrol. 2021 Mar;41(2):114-125. doi: 10.1016/j.semnephrol.2021.03.006.
4
A practical guide to male hypogonadism in the primary care setting.男性原发性性腺功能减退症的实用指南。
Int J Clin Pract. 2010 May;64(6):682-96. doi: 10.1111/j.1742-1241.2010.02355.x.
5
Gonadal dysfunction in men with chronic kidney disease: clinical features, prognostic implications and therapeutic options.男性慢性肾脏病患者的性腺功能障碍:临床特征、预后意义和治疗选择。
J Nephrol. 2012 Jan-Feb;25(1):31-42. doi: 10.5301/JN.2011.8481.
6
Effects of hormonal changes on sarcopenia in chronic kidney disease: where are we now and what can we do?激素变化对慢性肾脏病肌少症的影响:我们现在在哪里,我们能做些什么?
J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):1380-1392. doi: 10.1002/jcsm.12839. Epub 2021 Oct 21.
7
Visceral Adipose Tissue and Leptin Hyperproduction Are Associated With Hypogonadism in Men With Chronic Kidney Disease.内脏脂肪组织与瘦素过度产生与慢性肾脏病男性性腺功能减退有关。
J Ren Nutr. 2017 Jul;27(4):243-248. doi: 10.1053/j.jrn.2017.01.023. Epub 2017 Mar 31.
8
Late-onset hypogonadism.迟发性性腺功能减退症。
Med Clin North Am. 2011 May;95(3):507-23, x. doi: 10.1016/j.mcna.2011.03.001.
9
Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease.男性慢性肾脏病患者存在睾丸酮缺乏,这会导致贫血,并降低对红细胞生成刺激剂的反应性。
Nephrol Dial Transplant. 2012 Feb;27(2):709-15. doi: 10.1093/ndt/gfr288. Epub 2011 May 26.
10
Male Reproductive Endocrine Disorders.男性生殖内分泌紊乱。
Prim Care. 2024 Sep;51(3):455-466. doi: 10.1016/j.pop.2024.04.003. Epub 2024 May 23.

引用本文的文献

1
Emerging trends in functional molecularly imprinted polymers for electrochemical detection of biomarkers.用于生物标志物电化学检测的功能性分子印迹聚合物的新趋势。
Biomicrofluidics. 2024 May 17;18(3):031503. doi: 10.1063/5.0194200. eCollection 2024 May.
2
Exposure to the Chinese famine during early life increases the risk of frailty in adulthood: Evidence from the China Health and Retirement Longitudinal Study.早年经历中国饥荒会增加成年后身体虚弱的风险:来自中国健康与养老追踪调查的证据。
Prev Med Rep. 2025 Jun 18;56:103145. doi: 10.1016/j.pmedr.2025.103145. eCollection 2025 Aug.
3
Testosterone Therapy in Older Men: Present and Future Considerations.老年男性的睾酮治疗:现状与未来考量
Drugs Aging. 2025 Apr 27. doi: 10.1007/s40266-025-01209-1.
4
The Usefulness of Testosterone in Saliva Tests to Detect Testosterone Deficiency in Men with Advanced Chronic Kidney Disease: A Single-Center Study.唾液检测睾酮在晚期慢性肾脏病男性患者中检测睾酮缺乏的效用:一项单中心研究
J Clin Med. 2025 Apr 19;14(8):2818. doi: 10.3390/jcm14082818.
5
Positive Association Between the Cardiometabolic Index and the Risk of Male Biochemical Androgen Deficiency in Adults.成人心脏代谢指数与男性生化雄激素缺乏风险之间的正相关关系。
Kaohsiung J Med Sci. 2025 Jul;41(7):e70024. doi: 10.1002/kjm2.70024. Epub 2025 Apr 9.
6
Comprehensive Review of Lipid Management in Chronic Kidney Disease and Hemodialysis Patients: Conventional Approaches, and Challenges for Cardiovascular Risk Reduction.慢性肾脏病和血液透析患者血脂管理的全面综述:传统方法及降低心血管风险面临的挑战
J Clin Med. 2025 Jan 20;14(2):643. doi: 10.3390/jcm14020643.
7
Regulation of the blood-brain barrier function by peripheral cues in health and disease.健康与疾病状态下外周信号对血脑屏障功能的调节
Metab Brain Dis. 2024 Dec 13;40(1):61. doi: 10.1007/s11011-024-01468-8.
8
Kidney disease and reproductive health.肾脏疾病与生殖健康。
Nat Rev Nephrol. 2025 Feb;21(2):127-143. doi: 10.1038/s41581-024-00901-6. Epub 2024 Nov 5.
9
Association between the weight-adjusted-waist index and testosterone deficiency in adult males: a cross-sectional study.体重调整腰围指数与成年男性睾酮缺乏症的相关性:一项横断面研究。
Sci Rep. 2024 Oct 26;14(1):25574. doi: 10.1038/s41598-024-76574-9.
10
Sexual dimorphism in a mouse model of Friedreich's ataxia with severe cardiomyopathy.伴有严重心肌病的弗里德里希共济失调症小鼠模型中的性别二态性。
Commun Biol. 2024 Oct 3;7(1):1250. doi: 10.1038/s42003-024-06962-4.

本文引用的文献

1
Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism.英国内分泌学会男性性腺功能减退症睾酮治疗指南
Clin Endocrinol (Oxf). 2022 Feb;96(2):200-219. doi: 10.1111/cen.14633. Epub 2021 Nov 22.
2
Association between low testosterone and anaemia: Analysis of the National Health and Nutrition Examination Survey.低睾酮与贫血的关联:国家健康与营养调查分析。
Andrologia. 2021 Dec;53(11):e14210. doi: 10.1111/and.14210. Epub 2021 Aug 9.
3
Population Pharmacokinetic Modeling and Simulations to Evaluate a Potential Dose Regimen of Testosterone Undecanoate in Hypogonadal Males.人群药代动力学建模和模拟评估十一酸睾酮在男性性腺功能减退症患者中的潜在剂量方案。
J Clin Pharmacol. 2021 Dec;61(12):1618-1625. doi: 10.1002/jcph.1939. Epub 2021 Sep 12.
4
Testosterone Deficiency, Long-Term Testosterone Therapy, and Inflammation.睾酮缺乏、长期睾酮治疗与炎症。
J Cardiovasc Pharmacol Ther. 2021 Nov;26(6):638-647. doi: 10.1177/10742484211032402. Epub 2021 Jul 12.
5
European Association of Urology Guidelines on Sexual and Reproductive Health-2021 Update: Male Sexual Dysfunction.欧洲泌尿外科学会 2021 年性与生殖健康指南更新:男性性功能障碍。
Eur Urol. 2021 Sep;80(3):333-357. doi: 10.1016/j.eururo.2021.06.007. Epub 2021 Jun 26.
6
Depression and Associated Factors in Chinese Patients With Chronic Kidney Disease Without Dialysis: A Cross-Sectional Study.未透析的中国慢性肾脏病患者的抑郁状况及相关因素:一项横断面研究。
Front Public Health. 2021 May 28;9:605651. doi: 10.3389/fpubh.2021.605651. eCollection 2021.
7
Association of sarcopenia with mortality and end-stage renal disease in those with chronic kidney disease: a UK Biobank study.肌肉减少症与慢性肾脏病患者死亡率和终末期肾病的关系:英国生物库研究。
J Cachexia Sarcopenia Muscle. 2021 Jun;12(3):586-598. doi: 10.1002/jcsm.12705. Epub 2021 May 5.
8
Testosterone Therapy Effects on Bone Mass and Turnover in Hypogonadal Men with Type 2 Diabetes.睾酮治疗对 2 型糖尿病性腺功能减退男性骨量和代谢的影响。
J Clin Endocrinol Metab. 2021 Jul 13;106(8):e3058-e3068. doi: 10.1210/clinem/dgab181.
9
Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial.生活方式干预项目中纳入的男性接受睾酮治疗以预防或逆转 2 型糖尿病(T4DM):一项随机、双盲、安慰剂对照、为期 2 年的 3b 期试验。
Lancet Diabetes Endocrinol. 2021 Jan;9(1):32-45. doi: 10.1016/S2213-8587(20)30367-3.
10
Advanced Chronic Kidney Disease is a Strong Predictor of Hypogonadism and is Associated with Decreased Lean Tissue Mass.晚期慢性肾脏病是性腺功能减退的有力预测指标,并与瘦组织质量降低相关。
Int J Nephrol Renovasc Dis. 2020 Nov 5;13:319-327. doi: 10.2147/IJNRD.S275554. eCollection 2020.